Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biora Therapeutics, Inc. - Common Stock (NQ: BIOR )

2.200 +0.040 (+1.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biora Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Lightning eMotors Shares Are Trading Lower By 9%; Here Are 20 Stocks Moving Premarket
Gainers Broadwind, Inc. (NASDAQ: BWEN) rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start off the day with a breakdown of the biggest pre-market stock movers making the news on Wednesday morning! 
Via InvestorPlace
Looking Into Biora Therapeutics's Return On Invested Capital
Via Benzinga
Recap: Biora Therapeutics Q2 Earnings
  Biora Therapeutics (NASDAQ:BIOR) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Tesla, Amazon, Biora Therapeutics, Riot Platforms, Netflix: Why These 5 Stocks Are Drawing Investors' Attention Today
Major Wall Street indices closed in the green on Tuesday as investors and traders kept their eyes glued to the crucial consumer price inflation data due on Thursday. Federal Reserve Chair Jerome... 
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's trading, 71 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 63 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 31 stocks hit new 52-week lows. 
Via Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results. 
Via Benzinga
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday. 
Via Benzinga
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. 
Via Benzinga
Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital. 
Via Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 44 companies hit new 52-week lows. 
Via Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870. 
Via Benzinga
Why Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket
Gainers Windtree Therapeutics, Inc (NASDAQ: WINT) rose 50.7% to $0.4827 in pre-market trading after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European... 
Via Benzinga
Biora Therapeutics's Return on Invested Capital Insights
According to Benzinga Pro data, during Q2, Biora Therapeutics (NASDAQ:BIOR) posted sales of $104 thousand. Earnings were up 60.07%, but Biora Therapeutics still reported an overall loss of $5.51... 
Via Benzinga
Biora Therapeutics Earnings: A Preview
  Biora Therapeutics (NASDAQ:BIOR) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Avalon Globocare (NASDAQ:AVCO) stock rose 14.8% to $0.54 during Tuesday's after-market session. The market value of their outstanding shares is at $47.8 million. 
Via Benzinga
PLTR Stock Falls Another 5% as RBC Downgrades Palantir
Palantir Technologies (PLTR) stock is slipping on Tuesday as investors react to a downgrade for the shares from RBC Capital Markets. 
Via InvestorPlace
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380. 
Via Benzinga
Why Is GoodRx (GDRX) Stock Down Today?
GoodRx (GDRX) stock is slipping on Tuesday despite the healthcare company beating out estimates for the first quarter of 2022. 
Via InvestorPlace
BIOR Stock Starts Trading as Progenity’s Rebrand Takes Shape. What to Know.
Biora's product is supposed to enable biologics to be delivered directly to GI tracts. BIOR stock is a favorite of retail investors. 
Via InvestorPlace
30 Stocks Moving in Tuesday's Pre-Market Session
Gainers Vroom, Inc. (NASDAQ: VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results. 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.